COMSX | MOGLX | COMSX / MOGLX | |
Total Expense Ratio | 0.95 | 0.91 | 104% |
Annual Report Gross Expense Ratio | 1.31 | 5.56 | 24% |
Fund Existence | 3 years | 9 years | - |
Gain YTD | -29.599 | 5.850 | -506% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 101M | 4.1M | 2,462% |
Annual Yield % from dividends | 0.00 | 1.40 | - |
Returns for 1 year | -18.40 | 16.54 | -111% |
Returns for 3 years | N/A | 6.48 | - |
Returns for 5 years | N/A | 8.30 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBMQ | 25.29 | -0.02 | -0.08% |
iShares iBonds Dec 2028 Term Muni Bd ETF | |||
FEMB | 28.36 | -0.11 | -0.39% |
First Trust Emerging Mkts Lcl Ccy Bd ETF | |||
DGZ | 6.75 | -0.04 | -0.66% |
DB Gold Short ETN | |||
TSPA | 37.55 | -0.38 | -1.00% |
T. Rowe Price US Equity Research ETF | |||
BIB | 47.37 | -0.62 | -1.29% |
ProShares Ultra Nasdaq Biotechnology |